rss
Evid Based Nurs 13:50-51 doi:10.1136/ebn1047
  • Therapeutics
  • Randomised controlled trial

Nicotine patch plus lozenge gives greatest increases in abstinence from smoking at 6 months compared with placebo; smaller effects seen with nicotine patch alone, bupropion or nicotine lozenges alone or combined

  1. Lynne Buchanan
  1. Correspondence to Lynne Buchanan
    Associate Professor, University of Nebraska Medical Center College of Nursing, 985330 Nebraska Medical Center CON, Omaha, NE 68198-5330, USA; lbuchanan{at}unmc.edu

Commentary on:

The US Public Health Service recommends five nicotine replacement therapy (NRT) products and two non-nicotine medications (bupropion and varenicline).1 The NRT products are the most commonly used medications in clinical settings.2 Bupropion and varenicline, although relatively safe and effective, have recent black box warnings and enhanced surveillance recommendations for patients with mental health problems, making the NRT products alone or in combination a more appealing drug of choice.3 Piper and colleagues' study is important because there have been few head-to-head comparisons of the effectiveness of these first-line medications, in particular the nicotine patch plus nicotine lozenge.

This was a well-designed, longitudinal, randomised placebo-controlled clinical trial examining a selection …

This article has not yet been cited by other articles.

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article